0.012
0.00 (0.00%)
| Previous Close | 0.012 |
| Open | 0.012 |
| Volume | 334,060 |
| Avg. Volume (3M) | 1,404,280 |
| Market Cap | 8,774,856 |
| Price / Sales | 5.46 |
| Price / Book | 9.29 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
| Profit Margin | -95.80% |
| Operating Margin (TTM) | -113.21% |
| Diluted EPS (TTM) | 0.000 |
| Quarterly Revenue Growth (YOY) | -19.50% |
| Total Debt/Equity (MRQ) | 18.58% |
| Current Ratio (MRQ) | 1.87 |
| Return on Assets (TTM) | -43.41% |
| Return on Equity (TTM) | -92.34% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Scientific & Technical Instruments (AU) | Mixed | Mixed |
| Scientific & Technical Instruments (Global) | Bullish | Bullish | |
| Stock | DORSAVI FPO [DVL] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 2.0 |
| Average | 1.25 |
|
DorsaVi Ltd is engaged in the development and sale of motion analysis technologies. Its technologies are commercialized via license, sale, or fixed-fee consultancy. The company makes wearable sensors, software, and sophisticated algorithms that measure movement and muscle activation at around 200 frames per second. The company's products include ViSafe (Workplace), ViMove (Clinic), and others. The firm operates in two reportable segments: Clinical, and Workplace. A majority of its revenue is generated from the Clinical segment. Geographically, the company derives maximum revenue from the United States of America, and the rest from Australia, and Europe. |
|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Investment Style | Small Value |
| % Held by Insiders | 51.21% |
| % Held by Institutions | 13.34% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |